Experiences of patients undergoing repeated intravitreal anti-vascular endothelial growth factor injections for neovascular age-related macular degeneration

Grants

Funding Acknowledgements

This work was supported by an investigator-initiated research grant from Bayer Australia Ltd, an Orthoptics Australia (Victorian Branch) Small Project Research Grant and a La Trobe University Postgraduate Support Grant. This research was carried out whilst the first author was the recipient holder of a La Trobe University Postgraduate Research Scholarship. The authors do not have any financial interest in the material presented.